
MUTATIONAL ANALYSIS OF MITOCHONDRIAL tRNA GENES
IN PATIENTS WITH LUNG CANCER He ZF, Zheng LC, Xie DY, Yu SS, Zhao J *Corresponding Author: Dr. Jun Zhao, First Affiliated Hospital, Soochow University, Shizi Road, 215006, Suzhou, People’s
Republic of China. Tel./Fax: +86-0512-65223637. E-mail: zhaojsz001@163.com page: 45
|
RESULTS
Mutational Analysis of the Mitochondrial tRNA
Genes. Mutational screening of the 22 mt-tRNA genes
led us to identify five potential pathogenic mutations:
tRNAAla T5655C, tRNAArg T10454C, tRNALeu(CUN) A12330G,
tRNASer(UCN) T7505C and tRNAThr G15927A. Of these, the
T5655C mutation was detected in one out of 200 patients
(0.5%), the T10454C mutation was detected in two patients
(1.0%), the A12330G mutation was detected in three patients
(1.5%), the T7505C mutation was presented in one
patient (0.5%) and the G15927A mutation was presented
in four patients (2.0%). However, none of these mutations
were found in the healthy controls. The characterization of
each mt-tRNA mutation is listed in Table 1 and Figure 1.
Phylogenetic Conservation Analysis. To see whether
these mutations contributed to the genetic susceptibility
of lung cancer, we performed the phylogenetic conservation
analysis for each mt-tRNA mutations. We found that
all these mutations exhibited high levels of CI (100.0%),
indicating that these mutations may play important roles
in lung cancer.
The Pathogenicity Scoring System for These Mitochondrial
tRNA Mutations. According to the revised
pathogenicity scoring system, we found that the total score
of the T5655C, T10454C, A12330G, T7505C and G15927A
mutations were 11, 6, 14, 11 and 15 points, respectively, it
seemed that except for the T10454C mutation, other mutations
should be classified as “definitely pathogenic” (Table 2).
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|